Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03364400 |
Title | Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Vigeo Therapeutics, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Florida Cancer Specialists | Sarasota | Florida | 34232 | United States | Details | |
Northwestern Memorial Hospital | Chicago | Illinois | 60611 | United States | Details | |
Horizon Oncology Center | Lafayette | Indiana | 47905 | United States | Details | |
The Johns Hopkins Hospital | Baltimore | Maryland | 21287 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | United States | Details | |
Beth Israel | Boston | Massachusetts | 02215 | United States | Details | |
Case Western Reserve University | Cleveland | Ohio | 44106 | United States | Details | |
Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
University of Oklahoma | Oklahoma City | Oklahoma | 73104 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
START | San Antonio | Texas | 78229 | United States | Details |